لوگوی انجمن

Iran Finance Association

Held in Tehran Stock Exchange: Pharmaceutical industry analysis meeting in the glass hall

The report of public relations and international affairs of the Tehran Stock Exchange, this meeting was held in the building of the Tehran Stock Exchange with the cooperation of the Monthly Stock Exchange and the vice president of publishers and member affairs of this company. A number of senior managers of pharmaceutical companies and holdings, such as Tipico, Shafa, Sinadaro, Obidi Pharmaceutical Group, Iran Antibiotics, etc., as well as active analysts in the pharmaceutical industry from Sanat and Madan Bank brokerage companies, Kian Financial Group, Firouzeh Financial Group , Maskan Bank capital, Karisma Financial Group, Farabi Basket and… were present and presented and exchanged useful information in the form of analytical reports and a question and answer session.

Ali Namaki, editor-in-chief of “Bours” monthly, said at the beginning of the pharmaceutical industry analysis meeting while congratulating the global investor week: The pharmaceutical industry in the country consists of three sectors: “Raw Materials”, “Finished Product” and “Distribution” and the focus of this meeting is the “Finished Product” sector in this industry.

The secretary of the Iranian Financial Association stated that the purpose of holding analytical meetings and face-to-face dialogue between companies of each industry and analysts in that field is to increase transparency in the capital market and create understanding between both parties and continued: In order to provide conditions that, on the one hand, the realities of that industry are closely understood by the analysts, and on the other hand, the companies active in this industry are more familiar with the concerns of the analysts.

It is necessary to mention issues such as the latest pricing status of the pharmaceutical industry, the government’s foreign exchange policies and the allocation of foreign currency to companies in this industry, the state of working capital in the pharmaceutical industry, export markets, the effects of Darvar plan, changes in profit margins, challenges and the future of the industry, etc. It was one of the focal points of this meeting.

Source: Tehran Stock Exchange